Patient2Trial: From patient to participant in clinical trials using large language models
Surabhi Datta, Xiaoyan Wang(Yantai University), Roger Gildersleeve(Intelligent Medical Objects (United States)), Lizheng Shi(Tulane University), Pércío S. Gulko(Icahn School of Medicine at Mount Sinai), Jonathan Gold(Intelligent Medical Objects (United States)), Hua Xu(Tohoku University), Mitchell K. Higashi(Health Economics and Outcomes Research (United Kingdom)), Jingqi Wang(Intelligent Medical Objects (United States)), Kyeryoung Lee(Intelligent Medical Objects (United States)), Hunki Paek, Chunhua Weng(Columbia University Irving Medical Center), Deepak Pillai(Intelligent Medical Objects (United States)), Liang‐Chin Huang(Dairy Management)
Cited by 7
Related Papers
Systematic comparison of phenome-wide association study of electronic medical record data and genome-wide association study data
|Nature Biotechnology|2013|1.1k
Genome-wide polygenic score to predict chronic kidney disease across ancestries
|Nature Medicine|2022|162
PDBe-KB: a community-driven resource for structural and functional annotations
|Nucleic Acids Research|2019|138
Predicting adverse side effects of drugs
|BMC Genomics|2011|132